CMV infections affect more than just patients with compromised immune systems, resear... ( An infection due to a virus called c...)

CMV infections affect more than just patients with compromised immune systems, researchers find

Date:7/24/2008

An infection due to a virus called cytomegalovirus (CMV), which most commonly affects people with compromised immune systems, can also affect hospital intensive-care patients who have no immune-system problems, University of Washington researchers have found. CMV infection is also associated with longer hospital and intensive-care unit (ICU) stays independent of other causes, according to the study, published July 23 in JAMA, the Journal of the American Medical Association.

About half of all healthy adults in the United States are exposed to CMV during their life, researchers estimate, and control the infection with their immune system, often without even experiencing symptoms. In some people with reduced immune function, such as organ-transplant recipients, the virus can re-activate in the body and cause serious health problems.

In this study, researchers looked at CMV reactivation in 120 patients with no immune-system problems who were admitted to a hospital ICU. They also analyzed how CMV reactivation affected a patient's long-term health outcomes, including the amount of time the patient had to spend in the hospital or ICU and their risk of death.

The researchers found that CMV reactivation was surprisingly common in ICU patients, with about 30 percent exhibiting an active CMV infection in their bloodstream at various points during the 30-day study period. Even when controlling for other possible variables, CMV reactivation was strongly associated with a longer hospital and ICU stay for patients.

"Other studies have looked at the reactivation rate of CMV, but what makes this study different is that we're looking at people with apparently normal immune systems who were being treated in the ICU for trauma or another medical problem," explained Dr. Ajit Limaye, associate professor of medicine and laboratory medicine at the UW, who led the study. "A substantial number of these patients had CMV reactivate in
'/>"/>

Contact: Justin Reedy
jreedy@u.washington.edu
206-685-0382
University of Washington
Source:Eurekalert

2

GOOD

Page: 1 2
Related biology news :

1. Analysis of RNA role in spreading disease advances study of damaging plant infections
2. Bacterial infections in premature babies more common than previously realized
3. New drug targets may fight tuberculosis and other bacterial infections in novel way
4. Bacteria that cause urinary tract infections invade bladder cells
5. Best treatment identified to reduce deadly Staph infections
6. Gamma interferon could aid fight against fungal infections
7. Scripps research team blocks bacterial communication system to prevent deadly staph infections
8. Handbook helps parents deal with childhood infections
9. Evidence of a relationship between swimming babies and infections
10. Nutrient pollution drives frog deformities by ramping up infections, says CU-Boulder study
11. UCLA/VA partners with ASU to advance biosensor technology for urinary tract infections

Post Your Comments:

(Date:5/18/2012)... clears the mind. It gets the blood pumping and ... familiar territory, but Dartmouth,s David Bucci thinks there is ... years there have been data suggesting that neurobiological changes ... here," says Bucci, an associate professor in the Department ... Bucci and his collaborators have revealed important new findings: ...

(Date:5/17/2012)... increasing opportunities to participate in genetic testing that ... a disease. Receiving these results does not appreciably ... potentially costly follow-up health services, according to a ... of Health and colleagues at other institutions. , ... online issue of Genetics in Medicine ...

(Date:5/17/2012)... May 17th 2012. Wiley-Blackwell, the scientific, technical, medical ... Inc., today announced the launch of Food Science ... Access publishing program. The journal will provide authors with ... latest research and will be published in collaboration with ... Science & Technology and other prominent societies. , ...

[0] Dartmouth researchers are learning how exercise affects the brain [0] NIH-led study finds genetic test results do not trigger increased use of health services [0] Wiley-Blackwell launches new open-access journal: Food Science & Nutrition

... to the public and press on Wednesday 14 to Friday ... 5:15pm, Wednesday 14th November , Where: Owen Glenn Building, Wynyard ... be launched with a public symposium on Wednesday 14 November. ... on other days by arrangement. , With evidence in hand ...

... the most serious threats to child health in developing ... groundbreaking work by an international consortium led by the ... grant from the Bill & Melinda Gates Foundation. , ... easy-to-use diagnostic tool giving a clear, reliable indication of ...

... major study that will provide a new window into ... the La Jolla Institute for Allergy & Immunology (LIAI) ... study, funded by the National Institute of Allergy and ... Health, could lead to revolutionary new approaches for treating ...

Other Biology News:How much fish have we got? 2 How much fish have we got? 3 Life-saving clean water project secures $13M from Bill & Melinda Gates Foundation 2 NIH selects LIAI for major study on allergy molecular causes and possible treatments 2 NIH selects LIAI for major study on allergy molecular causes and possible treatments 3 NIH selects LIAI for major study on allergy molecular causes and possible treatments 4

How much fish have we got?Life-saving clean water project secures $13M from Bill & Melinda Gates Foundation NIH selects LIAI for major study on allergy molecular causes and possible treatments

(Date:5/16/2012)... YORK, May 16, 2012 ... research report is available in its ... Industry http://www.reportlinker.com/p090668/Global-Biotechnology-Instrumentation-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_ ... worldwide markets for Biotechnology Instrumentation in ... Segments: DNA Synthesizers, Protein/Peptide Synthesizers, DNA ...

(Date:5/16/2012)... May 16, 2012 MultiCell Technologies, Inc. ... is pleased to announce representatives from the ... MCT-465 and MCT-485 at CIMT 2012 ( ... cancer immunotherapy research and development. CIMT 2012 ... Mainz, Germany. The title of the poster ...

(Date:5/15/2012)... Vermillion, Inc. (NASDAQ: VRML ), a leading ... the first quarter ended March 31, 2012. ... the volume of OVA1®, the company,s flagship diagnostic test ... was generally in line with the forecast set by ... 28% to 3,952 from the same year-ago quarter. ...

(Date:5/15/2012)... -- Cardium Therapeutics (NYSE Amex: CXM ... first quarter ended March 31, 2012, and other ... In addition to the announcement ... its goals for 2012, which were outlined in ... advance commercialization of its new Excellagen® advanced, physician-use ...

[0] Global Biotechnology Instrumentation Industry [0] MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models [0] Vermillion Reports First Quarter 2012 Results [0] Cardium Presents First Quarter 2012 Financial Results and Recent Developments

... Inc., the pioneer,in scalable, high performance cell loading ... Demonstration of the MaxCyte STX Scalable,Transfection System on ... the,A/C/T Assays & Cellular Targets Conference in San ... Vice President of Research and,Development at MaxCyte, "The ...

... has,announced the launch of a new "Nursing School" section ... portal section is designed to assist,nursing school educators in ... assist students with research promoting patient safety,patient handling and ... is a pro bono injury prevention,site designed to help ...

... Helix BioPharma announced,today that Dr. Heman Chao, ... be presenting L-DOS47 research findings at the National,Research ... of the,Genomics and Health Initiative, today in Saskatoon, ... the NRC, government,departments and private industry and covers ...

Other Biology Technology:MaxCyte Debuts the STX Scalable Transfection System at the A/C/T Assays & Cellular Targets Meeting 2 New Safe Lifting Patient Safety Resource for Nursing School Educators and Students 2 Helix BioPharma to Present L-DOS47 Research Findings at the National Research Council of Canada's Eighth Annual General Meeting of the Genomics and Health Initiative in Saskatoon, Canada 2 Helix BioPharma to Present L-DOS47 Research Findings at the National Research Council of Canada's Eighth Annual General Meeting of the Genomics and Health Initiative in Saskatoon, Canada 3

MaxCyte Debuts the STX Scalable Transfection System at the A/C/T Assays & Cellular Targets Meeting New Safe Lifting Patient Safety Resource for Nursing School Educators and Students Helix BioPharma to Present L-DOS47 Research Findings at the National Research Council of Canada's Eighth Annual General Meeting of the Genomics and Health Initiative in Saskatoon, Canada

Request Info...

5-bromo-4-chloro-3-indolyl b -D-galactopyranoside (X-Gal)...

Services include subcloning into an expression vector. Tagged protein will be expressed in small scale for testing yield and solubility and then in 1L culture for large scale affinity purification. E...

... Western Blot Analysis Kit is an ... developed by Biochain. It detects protein ... or yoctomole (10 -24 M) ... parts: Millennium Enhancer, protein interaction system ...

Biology Products:

Feline IL-10 ELISpot Development Kit from R&D Systems 5-bromo-4-chloro-3-indolyl b-D-galactopyranoside (X-Gal) from Molecular Probes (Invitrogen)Bacterial system service from Abgent Attoglow Western Blot Analysis Kit: Millennium Enhancer from BioChain

CMV infections affect more than just patients with compromised immune systems, resear...( An infection due to a virus called c...)